Oxford Biomedica Plc (OP: OXBDF )

3.970 -0.130 (-3.17%)

Streaming Delayed Price Updated: 1:48 PM EDT, Jun 25, 2024 Add to My Watchlist

Price and Volume

Volume	200
Open	3.970
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	4.100
Today's Range	3.970 - 3.970
52wk Range	2.090 - 5.900
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

July 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga Before The Bell: Kohl's Deal Talks Cancellation, Tesla's Racial Discrimination Lawsuit, Nio's Strong June Deliveries And Other Top Financial Stories Friday, July 1

July 01, 2022

CNBC Why Kohl’s Shares Are Plunging Today

Via Benzinga

Performance

YTD	+64.73%	+64.73%
1 Month	-7.89%	-7.89%
3 Month	+63.37%	+63.37%
6 Month	+52.69%	+52.69%
1 Year	-32.71%	-32.71%

More News

Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 Vaccine

July 01, 2022

Via Benzinga

The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program

February 01, 2022

Via Benzinga

Oxford Biomedica, Homology Medicines Enter Deal To Expand Viral Vector Offerings

January 28, 2022

Via Benzinga

Oxford BioMedica To Manufacture More Doses Of AstraZeneca's COVID-19 Vaccine, Upgrades 2021 Outlook

May 18, 2021

Via Benzinga

The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO

May 18, 2021

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.